This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).

Over 400 enforcement actions, including show cause notices, production stoppages, and license cancellations, have been taken ...

The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement ...

Ardena's drug product manufacturing facility in Somerset Advanced drug product manufacturing facility acquired by Ardena in ...

Your local pharmacy might be the next front in Donald Trump’s trade war. The president has in recent weeks promised to impose tariffs on all foreign-made medications, a move intended to encourage drug ...

Industry associations react to President Trump’s tariffs and what they could mean for the pharmaceutical supply chain.

Akums Drugs and Pharmaceuticals reported a 15% increase in adjusted profit after tax, reaching Rs 66.3 crore for the quarter ...

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...

“A 25% tariff on Canada and Mexico threatens to upend the very supply chains that have made U.S. manufacturing more ...

TGCHE and BDMAI sign MoU to bridge academia-pharma industry skill gap, aligning education with industry needs for workforce development.

U.S. President Donald Trump has repeatedly mentioned pharmaceuticals as another industry that could be targeted by tariffs, ...